Unknown Drug Interactions Because BPC-157 is not FDA-approved, theres limited understanding of how it might interact with prescription drugs, anabolic steroids, or supplements
They are often considered to be birthmarks
This pathway undercuts the main appeal of compounded versionslower pricesby offering an FDA-approved option that is safer and closely regulated
Subcutaneous injection protocol: Starting dose: 200 to 300 mcg daily Titration: Increase by approximately 100 mcg every 1 to 2 weeks as tolerated Target dose: 400 to 500 mcg daily by weeks 5 through 12 Frequency: Once daily, subcutaneous Cycle length: 8 to 12 weeks, with optional extension to 16 weeks Timing: Consistent daily timing, typically evening for sleep applications Oral/sublingual protocol: Duration: 30 days Frequency: 1 to 4 cycles per year Best combined with: Exercise and nutrient-rich diet Injection sites should be rotated between the abdomen, thighs, and upper arms to prevent lipohypertrophy and ensure consistent absorption
Explore medication, ESG, gastric balloon, and combination treatment options through a personalized consultation at EndoSlim Clinic NY
many require longterm nursing home care
